Ireland vs San Marino: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Ireland
81.0%
in 2025
San Marino
81.0%
in 2025
Ireland rank
113th
San Marino rank
113th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Ireland
- San Marino
How they compare
Ireland currently reports 81.0% against 81.0% in San Marino, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was San Marino ahead.
Ireland ranks 113th and San Marino ranks 113th of 194 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 85.7% | 24.3% | 61.4% | Ireland |
| 2020s | 84.0% | 81.5% | 2.5% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Ireland or San Marino?
- Ireland, at 81.0% against 81.0% in San Marino as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Ireland and San Marino?
- 0.0%, with Ireland ahead.
- How many years of comparable data are there for Ireland and San Marino?
- 18 years are reported by both, from 2008 to 2025.
- How do Ireland and San Marino rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ireland ranks 113th and San Marino ranks 113th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.